546 related articles for article (PubMed ID: 2403650)
21. [The risk of the occurrence of acute nonlymphoblastic leukemia in patients with malignant neoplasms undergoing radio- and chemotherapy].
Arkad'eva MA; Zaridze DG
Vopr Onkol; 1991; 37(11-12):1086-90. PubMed ID: 1669202
[TBL] [Abstract][Full Text] [Related]
22. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
Glanzmann C; Lütolf UM
Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
[TBL] [Abstract][Full Text] [Related]
23. Thyroid diseases after treatment of Hodgkin's disease.
Hancock SL; Cox RS; McDougall IR
N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
[TBL] [Abstract][Full Text] [Related]
24. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
26. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
de Gramont A; Rioux E; Drolet Y; Delage JM
Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
[TBL] [Abstract][Full Text] [Related]
27. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
28. Combined chemotherapy and radiotherapy for Hodgkin's disease.
Prosnitz LR; Roberts KB
Oncology (Williston Park); 1992 Mar; 6(3):113-28; discussion 131-2, 137. PubMed ID: 1533138
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
Fermé C; Eghbali H; Meerwaldt JH; Rieux C; Bosq J; Berger F; Girinsky T; Brice P; van't Veer MB; Walewski JA; Lederlin P; Tirelli U; Carde P; Van den Neste E; Gyan E; Monconduit M; Diviné M; Raemaekers JM; Salles G; Noordijk EM; Creemers GJ; Gabarre J; Hagenbeek A; Reman O; Blanc M; Thomas J; Vié B; Kluin-Nelemans JC; Viseu F; Baars JW; Poortmans P; Lugtenburg PJ; Carrie C; Jaubert J; Henry-Amar M;
N Engl J Med; 2007 Nov; 357(19):1916-27. PubMed ID: 17989384
[TBL] [Abstract][Full Text] [Related]
30. Incidence of acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome up to 10 years after treatment of Hodgkin's disease.
Pedersen-Bjergaard J; Larsen SO
N Engl J Med; 1982 Oct; 307(16):965-71. PubMed ID: 7110299
[TBL] [Abstract][Full Text] [Related]
31. Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
van Leeuwen FE; Chorus AM; van den Belt-Dusebout AW; Hagenbeek A; Noyon R; van Kerkhoff EH; Pinedo HM; Somers R
J Clin Oncol; 1994 May; 12(5):1063-73. PubMed ID: 8164031
[TBL] [Abstract][Full Text] [Related]
32. Incidence of second cancers in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Zauber AG; Bernstein L; Davis FG; Michel RP; Zanke B; Tan CT; Fuller LM; Mauch P
J Natl Cancer Inst; 1995 May; 87(10):732-41. PubMed ID: 7563150
[TBL] [Abstract][Full Text] [Related]
33. Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease.
Krikorian JG; Burke JS; Rosenberg SA; Kaplan HS
N Engl J Med; 1979 Mar; 300(9):452-8. PubMed ID: 366418
[TBL] [Abstract][Full Text] [Related]
34. Risk of leukemia after platinum-based chemotherapy for ovarian cancer.
Travis LB; Holowaty EJ; Bergfeldt K; Lynch CF; Kohler BA; Wiklund T; Curtis RE; Hall P; Andersson M; Pukkala E; Sturgeon J; Stovall M
N Engl J Med; 1999 Feb; 340(5):351-7. PubMed ID: 9929525
[TBL] [Abstract][Full Text] [Related]
35. Secondary leukemia following treatment for Hodgkin's disease.
Salvagno L; Simonato L; Sorarù M; Bianco A; Chiarion-Sileni V; Aversa SM; Camporese R; Garofolin P; Fiorentino M
Tumori; 1993 Apr; 79(2):103-7. PubMed ID: 8346559
[TBL] [Abstract][Full Text] [Related]
36. Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
Tester WJ; Kinsella TJ; Waller B; Makuch RW; Kelley PA; Glatstein E; DeVita VT
J Clin Oncol; 1984 Jul; 2(7):762-9. PubMed ID: 6547479
[TBL] [Abstract][Full Text] [Related]
37. Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
Tura S; Fiacchini M; Zinzani PL; Brusamolino E; Gobbi PG
J Clin Oncol; 1993 May; 11(5):925-30. PubMed ID: 8487056
[TBL] [Abstract][Full Text] [Related]
38. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease.
van Leeuwen FE; Klokman WJ; Stovall M; Hagenbeek A; van den Belt-Dusebout AW; Noyon R; Boice JD; Burgers JM; Somers R
J Natl Cancer Inst; 1995 Oct; 87(20):1530-7. PubMed ID: 7563187
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease.
Travis LB; Gospodarowicz M; Curtis RE; Clarke EA; Andersson M; Glimelius B; Joensuu T; Lynch CF; van Leeuwen FE; Holowaty E; Storm H; Glimelius I; Pukkala E; Stovall M; Fraumeni JF; Boice JD; Gilbert E
J Natl Cancer Inst; 2002 Feb; 94(3):182-92. PubMed ID: 11830608
[TBL] [Abstract][Full Text] [Related]
40. Second neoplasms in patients with Hodgkin's disease following combined modality therapy--the Yale experience.
Koletsky AJ; Bertino JR; Farber LR; Prosnitz LR; Kapp DS; Fischer D; Portlock CS
J Clin Oncol; 1986 Mar; 4(3):311-7. PubMed ID: 3950674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
